Votre Référence pour l’Hépatite C au Québec
Is hep C curable ?
Is Hep C Curable? Here’s a comprehensive guide.
Hepatitis C, once considered a chronic and potentially life-threatening liver disease, has undergone a revolutionary transformation in terms of treatment and curability. The answer to the question « Is hep C curable? » is a resounding yes, thanks to groundbreaking advancements in medical science.
Key Points:
- Acute Hepatitis C: About 25% of people recover completely without treatment.
- Chronic Hepatitis C: Can be cured with antiviral medications.
- Treatment Duration: Typically 8-24 weeks.
- Sustained Virologic Response (SVR): Indicates the virus is undetectable 12 weeks after treatment, meaning the infection is cured.
Hepatitis C Treatment Revolutionized by Direct-Acting Antivirals (DAAs)
Direct-acting antiviral (DAA) drugs have revolutionized hepatitis C treatment, offering cure rates of over 95%. This remarkable success rate represents a significant leap from earlier treatments, which were less effective and often accompanied by severe side effects.
Modern Treatment: Short, Effective, and Well-Tolerated
Modern hepatitis C treatments typically involve a 12-week course of oral tablets, with minimal side effects. This is a vast improvement over previous regimens that could last up to 48 weeks and often included injectable medications. The shorter duration and improved tolerability have greatly increased patient compliance and treatment success rates.
Current Landscape of HCV Treatment in Canada
As of 2025, DAAs have been approved for use in Canada for people over 18 since 2014. The treatment has been simplified to the point where primary care providers, including nurse practitioners and family doctors, can now prescribe these medications.
Most public drug plans in Canada cover retreatment in cases of hepatitis C reinfection.
Key Hepatitis C Statistics for Canada in 2020:
- Total Cases: 6,736 reported cases of hepatitis C, with a national rate of 18.4 cases per 100,000 people
- Demographics:
- 62.3% of cases were male
- Male hepatitis C rate: 22.9 per 100,000
- Female hepatitis C rate: 13.7 per 100,000
- Age Group Highlights:
- Highest male rate: 30-39 years (43.1 per 100,000)
- Highest female rate: 25-29 years (32.3 per 100,000)
- Provincial Rates:
- Highest: Saskatchewan (38.5 per 100,000)
- Lowest: Quebec (9.2 per 100,000)
- COVID-19 Impact:
- Reduced testing and service access likely affected reporting
- Additional Insight: Estimated that one in four people with hepatitis C in Canada are unaware of their infection.
Reimbursement and Access Challenges
- Almost 90% of DAA claims are covered by public drug plans in Canada.
- The complexity of publicly funded prescription drug coverage has led to misunderstandings about DAA coverage among both patients and providers.
In conclusion
Is Hep C Curable? While hepatitis C remains curable in Canada with impressive treatment success rates, challenges in accessing and navigating the reimbursement system persist. As Canada moves forward, continued focus on simplifying drug coverage and improving healthcare accessibility will be crucial in the ongoing fight against hepatitis C.
Share this blog post to raise awareness about hepatitis C!
References:
- Hepatitis C in Canada: 2020 surveillance data update : https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hepatitis-c-canada-2020-surveillance-data-update.html
- National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019 : https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2022-48/issue-11-12-november-december-2022/ccdrv48i1112a07-eng.pdf
- Advances in hepatitis C treatment : https://www.health.vic.gov.au/your-health-report-of-the-chief-health-officer-victoria-2018/communicable-disease/advances-in
